Pharmaceutical Sales

Exploring the top 20 biopharma companies Q1 2024 market cap growths

April 30, 2024 - In the midst of economic uncertainties, fluctuating interest rates, and evolving Medicare Drug Price Negotiation policies, the top 20 global biopharmaceutical companies have achieved a promising start to the year. According to a GlobalData report, these companies collectively witnessed a notable increase in market capitalization during the first quarter, with a rise of 9.6% from $3.67...


More Articles

Mislabeled Packaging Results in Recalled ADHD Medication

by Veronica Salib

On January 24, 2024, Azurity Pharmaceuticals sent an announcement to the United States FDA recalling Zenzedi, a brand name for 30 mg dextroamphetamine sulfate tablets, for mislabeled packaging. The...

How Can Pharmaceutical Companies Meet Drug Launch Expectations

by Veronica Salib

Earlier this month, Deloitte published a report evaluating why so many drug launches failed to meet their expectations. According to data analyzed by the Deloitte Center for Health Solutions through the Life Sciences and Healthcare...

Ohio Attorney General Sues Pharmacy Benefit Managers Due to Collusion

by Veronica Salib

On Monday, March 27, 2023, Ohio Attorney General Dave Yost sued pharmacy benefit managers (PBMs) from multiple organizations for collusion on drug prices. The lawsuit names numerous defendants,...

Envision Pharma Group Acquires OKRA.ai

by Hayden Schmidt

This week, Envision Pharma Group announced that it had acquired OKRA.ai, a leader in artificial intelligence solutions for pharmaceutical operations. The transaction will add OKRA’s founder to...

Walgreens’ $1.67-Billion Specialty Pharmacy and Home Health Play

by Hayden Schmidt

On August 24, 2022, Walgreens lost a court case where it, and two other retail pharmacies, were ordered to pay $650.5 million to two Ohio Counties for their role in the opioid epidemic. One week after...

FTC Moves to Block Illumina Acquisition of PacBio, Citing Monopoly

by Kyle Murphy, PhD

On Tuesday, the Federal Trade Commission (FTC) took legal action to block Illumina Inc.’s acquisition of Pacific Biosciences of California (PacBio) as part of an administrative complaint alleging...

Top 5 Life Sciences Companies by Pharmaceutical Sales

by Kyle Murphy, PhD

The pharmaceutical industry is inching closer to the $1.3 trillion mark, with future growth anticipated for life sciences companies worldwide. According to the IQVIA Institute, the global...

How Could Drug Price Proposals Impact Pharma Company Profits?

by Sara Heath

The pharmaceutical industry could lose $1 trillion in overall revenue and still remain as one of the most lucrative industries in the country, according to research conducted in partnership between...